NSE · MANKIND
Mankind Pharma Limited
₹2,425.20
+0.87%
Market Cap
100,112.26 Cr
P/E Ratio
52.32
P/B Ratio
6.05
ROE
11.70%
ROCE
14.32%
Dividend Yield
—
52W High
₹2,674.00
52W Low
₹2,059.40
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 |
|---|---|---|
| Revenue | 4,030.59 Cr | 3,442.93 Cr |
| Net Profit | 574.09 Cr | 559.42 Cr |
| EPS | 13.76 | 13.44 |
| Operating Profit | 875.49 Cr | 821.09 Cr |
Shareholding pattern
Promoter
72.63%
Public
27.37%
FII
—
DII
—
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.